Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Promising results of the combination of radiotherapy and pembrolizumab in metastatic NSCLC].

Literature DB >> 32040692

[Promising results of the combination of radiotherapy and pembrolizumab in metastatic NSCLC].

Markus Hecht¹, Udo S Gaipl², Rainer Fietkau².

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2020 PMID： 32040692 DOI： 10.1007/s00066-019-01573-z

Source DB: PubMed Journal: Strahlenther Onkol ISSN： 0179-7158 Impact factor: 3.621

× No keyword cloud information.

6 in total

Review 1. Time to abandon single-site irradiation for inducing abscopal effects.

Authors: Eric D Brooks; Joe Y Chang
Journal: Nat Rev Clin Oncol Date: 2019-02 Impact factor: 66.675

2. Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8⁺ Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis.

Authors: Yu Jin Lim; Jaemoon Koh; Sehui Kim; Sang-Rok Jeon; Eui Kyu Chie; Kyubo Kim; Gyeong Hoon Kang; Sae-Won Han; Tae-You Kim; Seung-Yong Jeong; Kyu Joo Park; Hong-Gyun Wu
Journal: Int J Radiat Oncol Biol Phys Date: 2017-12-01 Impact factor: 7.038

3. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

Authors: Roy S Herbst; Paul Baas; Dong-Wan Kim; Enriqueta Felip; José L Pérez-Gracia; Ji-Youn Han; Julian Molina; Joo-Hang Kim; Catherine Dubos Arvis; Myung-Ju Ahn; Margarita Majem; Mary J Fidler; Gilberto de Castro; Marcelo Garrido; Gregory M Lubiniecki; Yue Shentu; Ellie Im; Marisa Dolled-Filhart; Edward B Garon
Journal: Lancet Date: 2015-12-19 Impact factor: 79.321

4. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

Authors: Daniel R Gomez; Chad Tang; Jianjun Zhang; George R Blumenschein; Mike Hernandez; J Jack Lee; Rong Ye; David A Palma; Alexander V Louie; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; James W Welsh; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Anne S Tsao; Boris Sepesi; Stephen G Swisher; John V Heymach
Journal: J Clin Oncol Date: 2019-05-08 Impact factor: 44.544

5. PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis.

Authors: Markus Hecht; Maike Büttner-Herold; Katharina Erlenbach-Wünsch; Marlen Haderlein; Roland Croner; Robert Grützmann; Arndt Hartmann; Rainer Fietkau; Luitpold V Distel
Journal: Eur J Cancer Date: 2016-07-25 Impact factor: 9.162

Review 6. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.

Authors: Anja Derer; Benjamin Frey; Rainer Fietkau; Udo S Gaipl
Journal: Cancer Immunol Immunother Date: 2015-11-21 Impact factor: 6.968